# MetaPharm Connect - UAT Sign-Off Templates

**Version:** 1.0
**Last Updated:** 2025-12-25

---

## Overview

This document contains all sign-off templates required for UAT completion. These templates ensure formal acceptance and documentation of the UAT process.

---

## Template 1: Role-Based Sign-Off

```
============================================================
                 UAT ROLE SIGN-OFF FORM
                 MetaPharm Connect
============================================================

USER ROLE: ________________________________________________

TESTER INFORMATION
------------------------------------------------------------
Full Name:         ________________________________________________
Organization:      ________________________________________________
Department:        ________________________________________________
Email:             ________________________________________________
Phone:             ________________________________________________

TESTING PERIOD
------------------------------------------------------------
Start Date:        ________________________________________________
End Date:          ________________________________________________
Total Hours:       ________________________________________________

TESTING SCOPE
------------------------------------------------------------
Test Cases Executed:     _______ / _______ (Completed / Total)
Test Cases Passed:       _______
Test Cases Failed:       _______
Test Cases Blocked:      _______
Pass Rate:               _______ %

DEFECTS
------------------------------------------------------------
Defects Reported:        _______
Critical Defects:        _______ (Open: _____ / Closed: _____)
High Defects:            _______ (Open: _____ / Closed: _____)
Medium Defects:          _______ (Open: _____ / Closed: _____)
Low Defects:             _______ (Open: _____ / Closed: _____)

FEATURE ASSESSMENT
------------------------------------------------------------
Please rate each feature you tested (1-5, where 5 is excellent):

| Feature                    | Functionality | Usability | Meets Needs |
|---------------------------|---------------|-----------|-------------|
| Authentication/Login       |               |           |             |
| Dashboard                  |               |           |             |
| Core Feature 1: __________ |               |           |             |
| Core Feature 2: __________ |               |           |             |
| Core Feature 3: __________ |               |           |             |
| Messaging                  |               |           |             |
| Reports                    |               |           |             |

OVERALL ASSESSMENT
------------------------------------------------------------
Overall System Rating (1-5):  _______

The system meets business requirements:
[ ] Fully   [ ] Partially   [ ] Does Not Meet

The system is ready for production use:
[ ] Yes   [ ] Yes with conditions   [ ] No

OUTSTANDING ISSUES
------------------------------------------------------------
Critical issues that must be resolved before go-live:
1. ___________________________________________________________
2. ___________________________________________________________
3. ___________________________________________________________

Issues that should be resolved but are not blockers:
1. ___________________________________________________________
2. ___________________________________________________________
3. ___________________________________________________________

RECOMMENDATIONS
------------------------------------------------------------
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________

SIGN-OFF DECISION
------------------------------------------------------------
Based on my testing, I hereby:

[ ] APPROVE this role's functionality for production release

[ ] CONDITIONALLY APPROVE with the following conditions:
    ___________________________________________________________
    ___________________________________________________________

[ ] DO NOT APPROVE (reasons):
    ___________________________________________________________
    ___________________________________________________________

SIGNATURE
------------------------------------------------------------
Tester Signature:    ________________________  Date: __________

Printed Name:        ________________________

Witness (if required): ______________________  Date: __________

============================================================
                    INTERNAL USE ONLY
============================================================
Received by UAT Lead: ______________________  Date: __________
Verified by QA Lead:  ______________________  Date: __________
============================================================
```

---

## Template 2: UAT Summary Sign-Off

```
============================================================
              UAT COMPLETION SIGN-OFF FORM
                  MetaPharm Connect
============================================================

PROJECT INFORMATION
------------------------------------------------------------
Project Name:      MetaPharm Connect Healthcare Platform
UAT Phase:         ________________________________________________
Version Tested:    ________________________________________________
UAT Period:        From ______________ To ______________

EXECUTIVE SUMMARY
------------------------------------------------------------
Overall UAT Status:  [ ] PASSED   [ ] PASSED WITH CONDITIONS   [ ] FAILED

Summary Statement:
____________________________________________________________
____________________________________________________________
____________________________________________________________

TESTING METRICS
------------------------------------------------------------
| Metric                    | Target    | Actual    | Status |
|---------------------------|-----------|-----------|--------|
| Test Cases Executed       | 100%      |     %     | [ ] Met|
| Critical Test Cases Pass  | 100%      |     %     | [ ] Met|
| High Test Cases Pass      | 95%       |     %     | [ ] Met|
| Open Critical Defects     | 0         |           | [ ] Met|
| Open High Defects         | 0         |           | [ ] Met|
| User Acceptance Rate      | 80%       |     %     | [ ] Met|

ROLE-BASED RESULTS
------------------------------------------------------------
| Role            | Tests | Passed | Failed | Acceptance |
|-----------------|-------|--------|--------|------------|
| Pharmacist      |       |        |        | [ ] Yes    |
| Doctor          |       |        |        | [ ] Yes    |
| Nurse           |       |        |        | [ ] Yes    |
| Delivery        |       |        |        | [ ] Yes    |
| Patient         |       |        |        | [ ] Yes    |

COMPLIANCE VERIFICATION
------------------------------------------------------------
| Requirement              | Status          | Evidence      |
|--------------------------|-----------------|---------------|
| HIPAA Compliance         | [ ] Pass [ ] Fail |               |
| GDPR Compliance          | [ ] Pass [ ] Fail |               |
| Swiss Healthcare Regs    | [ ] Pass [ ] Fail |               |
| Data Encryption          | [ ] Pass [ ] Fail |               |
| Audit Logging            | [ ] Pass [ ] Fail |               |
| MFA Implementation       | [ ] Pass [ ] Fail |               |

OUTSTANDING DEFECTS
------------------------------------------------------------
Critical (Must Fix Before Go-Live):
| ID     | Summary                              | Status    |
|--------|--------------------------------------|-----------|
|        |                                      |           |
|        |                                      |           |

High Priority (Should Fix Before Go-Live):
| ID     | Summary                              | Status    |
|--------|--------------------------------------|-----------|
|        |                                      |           |
|        |                                      |           |

Deferred to Post-Go-Live:
| ID     | Summary                              | Reason    |
|--------|--------------------------------------|-----------|
|        |                                      |           |
|        |                                      |           |

CONDITIONS FOR GO-LIVE
------------------------------------------------------------
[ ] All critical defects resolved
[ ] All high defects resolved or approved workaround
[ ] Compliance requirements met
[ ] Training materials prepared
[ ] Support team briefed
[ ] Rollback plan documented
[ ] Monitoring in place

Additional conditions:
1. ___________________________________________________________
2. ___________________________________________________________
3. ___________________________________________________________

STAKEHOLDER APPROVALS
============================================================

UAT Lead
------------------------------------------------------------
I confirm that UAT has been conducted according to the test plan
and the results accurately represent the system's readiness.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

Product Owner
------------------------------------------------------------
I confirm that the system meets business requirements and is
acceptable for production deployment.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

Development Lead
------------------------------------------------------------
I confirm that identified defects have been addressed and the
system is technically ready for production.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

QA Lead
------------------------------------------------------------
I confirm that testing was comprehensive and quality standards
have been met for production release.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

IT/Operations Lead
------------------------------------------------------------
I confirm that infrastructure and operational readiness
requirements have been met.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

Compliance Officer
------------------------------------------------------------
I confirm that compliance requirements have been verified and
the system meets regulatory standards.

Name:      ________________________
Signature: ________________________  Date: __________
Decision:  [ ] APPROVE   [ ] CONDITIONAL   [ ] REJECT

Executive Sponsor
------------------------------------------------------------
Based on the above approvals, I authorize:

[ ] GO - Proceed with production deployment
[ ] CONDITIONAL GO - Proceed after conditions met
[ ] NO GO - Do not proceed with deployment

Name:      ________________________
Signature: ________________________  Date: __________

FINAL GO/NO-GO DECISION
============================================================
Decision:           [ ] GO   [ ] NO GO   [ ] CONDITIONAL GO
Decision Date:      ________________________
Target Go-Live:     ________________________
Conditions (if any): ________________________________________
                    ________________________________________

============================================================
                  DOCUMENT CONTROL
============================================================
Version:     1.0
Created:     ________________________
Modified:    ________________________
Distribution: UAT Team, Development, QA, Compliance, Executive
============================================================
```

---

## Template 3: Healthcare Compliance Sign-Off

```
============================================================
           HEALTHCARE COMPLIANCE SIGN-OFF
                 MetaPharm Connect
============================================================

COMPLIANCE ASSESSMENT DATE: ________________________________

ASSESSOR INFORMATION
------------------------------------------------------------
Name:           ________________________
Title:          ________________________
Certification:  ________________________

HIPAA COMPLIANCE
============================================================

Technical Safeguards (45 CFR 164.312)
------------------------------------------------------------
| Requirement                        | Status    | Evidence |
|------------------------------------|-----------|----------|
| Access Control (164.312(a)(1))     | [ ] Pass  |          |
| - Unique User Identification       | [ ] Pass  |          |
| - Emergency Access Procedure       | [ ] Pass  |          |
| - Automatic Logoff                 | [ ] Pass  |          |
| - Encryption                       | [ ] Pass  |          |
| Audit Controls (164.312(b))        | [ ] Pass  |          |
| Integrity (164.312(c)(1))          | [ ] Pass  |          |
| - Data Validation                  | [ ] Pass  |          |
| Authentication (164.312(d))        | [ ] Pass  |          |
| - MFA Implementation               | [ ] Pass  |          |
| Transmission Security (164.312(e)) | [ ] Pass  |          |
| - TLS Configuration                | [ ] Pass  |          |

Administrative Safeguards (45 CFR 164.308)
------------------------------------------------------------
| Requirement                        | Status    | Evidence |
|------------------------------------|-----------|----------|
| Security Management Process        | [ ] Pass  |          |
| Workforce Security                 | [ ] Pass  |          |
| Information Access Management      | [ ] Pass  |          |
| Security Awareness Training        | [ ] Pass  |          |
| Security Incident Procedures       | [ ] Pass  |          |
| Contingency Plan                   | [ ] Pass  |          |
| Business Associate Agreements      | [ ] Pass  |          |

HIPAA Compliance Status: [ ] COMPLIANT   [ ] NON-COMPLIANT

GDPR COMPLIANCE
============================================================

Data Subject Rights (Chapter III)
------------------------------------------------------------
| Right                              | Status    | Tested   |
|------------------------------------|-----------|----------|
| Right of Access (Art. 15)          | [ ] Pass  | [ ] Yes  |
| Right to Rectification (Art. 16)   | [ ] Pass  | [ ] Yes  |
| Right to Erasure (Art. 17)         | [ ] Pass  | [ ] Yes  |
| Right to Restrict (Art. 18)        | [ ] Pass  | [ ] Yes  |
| Right to Portability (Art. 20)     | [ ] Pass  | [ ] Yes  |
| Right to Object (Art. 21)          | [ ] Pass  | [ ] Yes  |

Data Protection Principles (Art. 5)
------------------------------------------------------------
| Principle                          | Status    | Evidence |
|------------------------------------|-----------|----------|
| Lawfulness, Fairness, Transparency | [ ] Pass  |          |
| Purpose Limitation                 | [ ] Pass  |          |
| Data Minimization                  | [ ] Pass  |          |
| Accuracy                           | [ ] Pass  |          |
| Storage Limitation                 | [ ] Pass  |          |
| Integrity & Confidentiality        | [ ] Pass  |          |

GDPR Compliance Status: [ ] COMPLIANT   [ ] NON-COMPLIANT

SWISS HEALTHCARE REGULATIONS
============================================================

| Requirement                        | Status    | Evidence |
|------------------------------------|-----------|----------|
| HIN e-ID Integration               | [ ] Pass  |          |
| Cantonal Health Record APIs        | [ ] Pass  |          |
| Controlled Substance Tracking      | [ ] Pass  |          |
| Prescription Validity Rules        | [ ] Pass  |          |
| Professional Licensing Validation  | [ ] Pass  |          |

Swiss Healthcare Compliance: [ ] COMPLIANT   [ ] NON-COMPLIANT

NON-COMPLIANCE ISSUES
------------------------------------------------------------
| Issue                 | Severity | Remediation         |
|-----------------------|----------|---------------------|
|                       |          |                     |
|                       |          |                     |
|                       |          |                     |

COMPLIANCE CERTIFICATION
============================================================

I hereby certify that MetaPharm Connect has been assessed
against applicable healthcare regulations and:

[ ] MEETS all compliance requirements
[ ] MEETS requirements with noted exceptions (see above)
[ ] DOES NOT MEET compliance requirements

Recommendations:
____________________________________________________________
____________________________________________________________

Assessor Signature: ________________________  Date: __________

Compliance Officer
Approval:           ________________________  Date: __________

============================================================
```

---

## Template 4: Go-Live Authorization

```
============================================================
             GO-LIVE AUTHORIZATION FORM
                 MetaPharm Connect
============================================================

RELEASE INFORMATION
------------------------------------------------------------
Release Version:    ________________________
Release Date:       ________________________
Release Time:       ________________________
Release Type:       [ ] Full   [ ] Phased   [ ] Pilot

PRE-GO-LIVE CHECKLIST
============================================================

UAT Completion
------------------------------------------------------------
[ ] UAT sign-off obtained from all roles
[ ] All critical defects resolved
[ ] All high defects resolved or approved
[ ] Compliance sign-off obtained

Technical Readiness
------------------------------------------------------------
[ ] Production environment configured
[ ] Database migration tested
[ ] SSL certificates installed
[ ] DNS configured
[ ] Load balancer configured
[ ] Monitoring enabled
[ ] Alerting configured
[ ] Backup systems verified

Operational Readiness
------------------------------------------------------------
[ ] Support team trained
[ ] Escalation procedures documented
[ ] On-call schedule confirmed
[ ] Runbook reviewed
[ ] Rollback plan tested

Documentation
------------------------------------------------------------
[ ] User guides published
[ ] API documentation updated
[ ] Release notes prepared
[ ] Known issues documented

Communication
------------------------------------------------------------
[ ] Stakeholders notified
[ ] Users notified
[ ] Support channels ready
[ ] Status page updated

RISK ASSESSMENT
------------------------------------------------------------
| Risk                    | Probability | Impact | Mitigation |
|-------------------------|-------------|--------|------------|
|                         |             |        |            |
|                         |             |        |            |
|                         |             |        |            |

ROLLBACK PLAN
------------------------------------------------------------
Rollback Trigger:   ________________________________________
Rollback Time:      ________ minutes
Rollback Owner:     ________________________________________
Rollback Steps:
1. ___________________________________________________________
2. ___________________________________________________________
3. ___________________________________________________________

AUTHORIZATION
============================================================

I have reviewed all pre-go-live requirements and authorize
the production deployment of MetaPharm Connect.

Development Lead:   ________________________  Date: __________
                    [ ] AUTHORIZED

Operations Lead:    ________________________  Date: __________
                    [ ] AUTHORIZED

QA Lead:            ________________________  Date: __________
                    [ ] AUTHORIZED

Product Owner:      ________________________  Date: __________
                    [ ] AUTHORIZED

Executive Sponsor:  ________________________  Date: __________

                    [ ] GO-LIVE AUTHORIZED
                    [ ] GO-LIVE NOT AUTHORIZED

Reason (if not authorized):
____________________________________________________________
____________________________________________________________

============================================================
               POST-GO-LIVE VERIFICATION
============================================================
(To be completed after deployment)

Deployment Status:   [ ] SUCCESS   [ ] FAILED   [ ] ROLLED BACK

Deployment Time:     Start: __________ End: __________

Issues Encountered:
____________________________________________________________
____________________________________________________________

Verification Complete: ______________________  Date: __________

============================================================
```

---

## Digital Signature Instructions

For electronic signatures:

1. **PDF Signing**
   - Export template to PDF
   - Use Adobe Acrobat or DocuSign
   - Apply digital signature with timestamp

2. **GitHub Approval**
   - Create sign-off issue in GitHub
   - Use approval workflow
   - Link to UAT report

3. **Email Confirmation**
   - Email signed PDF to uat-signoff@metapharm-connect.ch
   - Include UAT session ID in subject

---

## Document Storage

All signed documents are stored in:
- **Primary:** SharePoint > MetaPharm > UAT > Sign-offs
- **Backup:** S3 bucket `metapharm-compliance/uat-signoffs/`
- **Retention:** 7 years per compliance requirements

---

*Templates Version 1.0 - MetaPharm Connect UAT*
